Several papers have reported that PRMT1 expression is elevated in various types of cancer, including lung cancer, bladder cancer, breast cancer and acute myeloid leukemia, and that PRMT1 knockdown induces the suppression of cancer cell growth and metastasis [14–16]. Here, PRMT1 is linked to breast cancer.